US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AN2 Therapeutics, Inc.

5.48

-0.0700-1.26%

Volume:215.42K

Turnover:1.19M

Market Cap:206.79M

PE:-5.27

High:5.67

Open:5.53

Low:5.40

Close:5.55

52wk High:7.19

52wk Low:1.00

Shares:37.74M

Float Shares:21.41M

Volume Ratio:1.00

T/O Rate:1.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0401

EPS(LYR):-1.1641

ROE:-50.12%

ROA:-30.80%

PB:2.72

PE(LYR):-4.71

Loading ...

Overview Company News Filings

AN2 Therapeutics presents clinical data supporting development of Epetraborole

AN2 Therapeutics Presents SOHO 2026 Data Backing Epetraborole Development for Polycythemia Vera

AN2 Therapeutics Names Cameron Trenor III as Chief Medical Officer in Initial Beneficial Ownership Filing

AN2 Therapeutics Names Cameron Trenor Chief Medical Officer

AN2 Therapeutics Appoints Cameron Trenor, M.d., as Chief Medical Officer

THOMSON REUTERS

AN2 Therapeutics Director Robin Shane Readnour Disposes of USD 212,486 Common Shares

AN2 Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

AN2 Therapeutics Rugi Bersih Q2 FY26 Melebar Jadi $ 8,19 Juta; Belanja R&D Naik 88,09% Jadi $ 6,02 Juta

AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights

THOMSON REUTERS

AN2 Therapeutics Q2 Net Income USD -8.185 Million

THOMSON REUTERS

AN2 Therapeutics Inc Expected to Post a Loss of 27 Cents a Share - Earnings Preview

AN2 Therapeutics Initiated at Buy by Guggenheim

U.S. Research Roundup- Anterix, Fidus Investment, Nextpower

AN2 Therapeutics initiated with a Buy at Guggenheim

One new option listing on July 17th

AN2 Therapeutics shareholders elect Class I directors at annual meeting

AN2 Therapeutics Says Chagas Disease Drug Shows Positive Preclinical, Early Human Data

MT Newswires Live

AN2 Therapeutics says oral AN2-502998 clears T. cruzi in primate study, supports Phase 2 in chronic Chagas disease

AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease

THOMSON REUTERS

AN2 Therapeutics - Phase 1 Study Shows Favorable Safety and No Dose-Limiting Toxicities for AN2-502998

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ANTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":5.48,"timestamp":1788292800000,"preClose":5.55,"halted":0,"volume":215423,"delay":0,"changeRate":-0.012612612612612505,"floatShares":21409300,"shares":37736200,"eps":-1.040051,"marketStatus":"Pre-Mkt","change":-0.07,"latestTime":"09-02 05:07:51 EDT","open":5.53,"high":5.67,"low":5.4,"amount":1186855.4615255,"amplitude":0.048649,"askPrice":7.38,"askSize":100,"bidPrice":5.08,"bidSize":111,"shortable":3,"etf":0,"ttmEps":-1.040051,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1648180800000,"exchange":"NASDAQ","adjPreClose":5.48,"postHourTrading":{"tag":"盘后","latestPrice":5.48,"preClose":5.48,"latestTime":"19:30 EDT","volume":67,"amount":367.12,"timestamp":1788305405634,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0027528546100317,"impliedVol":0.907,"impliedVolPercentile":0.1515},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","floatShares":21409300,"roa":"-30.80%","roe":"-50.12%","lyrEps":-1.164094,"volumeRatio":1.0027528546100317,"shares":37736200,"dividePrice":0,"high":5.67,"amplitude":0.048649,"preClose":5.55,"low":5.4,"week52Low":1,"pbRate":"2.72","week52High":7.19,"institutionHeld":0,"latestPrice":5.48,"committee":0.052133,"eps":-1.040051,"divideRate":0,"volume":215423,"delay":0,"ttmEps":-1.040051,"open":5.53,"prevYearClose":1.14,"prevWeekClose":5.58,"prevMonthClose":5.55,"prevQuarterClose":4.84,"fiveDayClose":5.66,"twentyDayClose":5.94,"sixtyDayClose":3.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"ANTX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2026-05-11","symbol":"ANTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2026-03-17","symbol":"ANTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.24,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2025-11-12","symbol":"ANTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-08-12","symbol":"ANTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":2,"updateTime":1784520000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANTX","date":"2026-08-31","current":-5.268972,"percent":0.275455,"low":-16.371108,"twenty":-7.521188,"median":-3.03478,"eighty":-0.751848,"high":-0.452319,"avg":-3.979768,"sd":3.639018,"marketCap":210568202},"quantilePoints":[{"date":"2022-03-25","current":-13.396124,"twenty":-13.256944,"median":-13.048173,"eighty":-12.797512,"marketCap":288592704},{"date":"2022-04-01","current":-13.735377,"twenty":-13.389165,"median":-13.082968,"eighty":-13.048173,"marketCap":295901220},{"date":"2022-04-08","current":-13.126462,"twenty":-13.389165,"median":-13.126462,"eighty":-13.048173,"marketCap":282783370},{"date":"2022-04-14","current":-12.195692,"twenty":-13.35611,"median":-13.056872,"eighty":-12.282634,"marketCap":262731799},{"date":"2022-04-22","current":-12.674125,"twenty":-13.265642,"median":-13.043824,"eighty":-12.188734,"marketCap":273038682},{"date":"2022-04-29","current":-13.596196,"twenty":-13.35611,"median":-13.048173,"eighty":-12.282634,"marketCap":292902855},{"date":"2022-05-06","current":-16.371108,"twenty":-13.735377,"median":-13.082968,"eighty":-12.639148,"marketCap":352682772},{"date":"2022-05-13","current":-12.634954,"twenty":-13.707541,"median":-13.048173,"eighty":-12.337661,"marketCap":343038993},{"date":"2022-05-20","current":-7.432326,"twenty":-13.556182,"median":-13.043824,"eighty":-12.180035,"marketCap":201787643},{"date":"2022-05-27","current":-10.426695,"twenty":-13.392645,"median":-13.013378,"eighty":-11.61546,"marketCap":283084780},{"date":"2022-06-03","current":-11.20566,"twenty":-13.378727,"median":-12.769812,"eighty":-10.726847,"marketCap":304233677},{"date":"2022-06-10","current":-6.882048,"twenty":-13.265642,"median":-12.632679,"eighty":-9.433336,"marketCap":186847596},{"date":"2022-06-17","current":-6.081643,"twenty":-13.265642,"median":-12.334802,"eighty":-8.368513,"marketCap":165116619},{"date":"2022-06-24","current":-6.253159,"twenty":-13.196052,"median":-12.186994,"eighty":-7.795366,"marketCap":169773257},{"date":"2022-07-01","current":-5.831517,"twenty":-13.172482,"median":-12.113054,"eighty":-7.105018,"marketCap":158325689},{"date":"2022-07-08","current":-6.424674,"twenty":-13.15991,"median":-11.715613,"eighty":-6.370361,"marketCap":174429895},{"date":"2022-07-15","current":-6.360356,"twenty":-13.1369,"median":-11.019852,"eighty":-6.253159,"marketCap":172683656},{"date":"2022-07-22","current":-5.881542,"twenty":-13.116023,"median":-10.573198,"eighty":-6.184553,"marketCap":159683875},{"date":"2022-07-29","current":-6.117376,"twenty":-13.077749,"median":-9.433336,"eighty":-5.990169,"marketCap":166086752},{"date":"2022-08-05","current":-7.28225,"twenty":-13.051653,"median":-8.550748,"eighty":-5.92728,"marketCap":197713085},{"date":"2022-08-12","current":-11.654946,"twenty":-13.048173,"median":-8.368513,"eighty":-5.964441,"marketCap":376023512},{"date":"2022-08-19","current":-11.973683,"twenty":-13.048173,"median":-8.836607,"eighty":-5.990169,"marketCap":386306920},{"date":"2022-08-26","current":-9.447843,"twenty":-13.042954,"median":-9.447843,"eighty":-6.034477,"marketCap":304815757},{"date":"2022-09-02","current":-7.685769,"twenty":-13.039474,"median":-9.296256,"eighty":-6.073067,"marketCap":247965969},{"date":"2022-09-09","current":-5.683139,"twenty":-13.031725,"median":-8.930422,"eighty":-5.955866,"marketCap":183355118},{"date":"2022-09-16","current":-5.310277,"twenty":-13.017412,"median":-8.532882,"eighty":-5.851527,"marketCap":171325470},{"date":"2022-09-23","current":-6.735572,"twenty":-12.958334,"median":-8.22201,"eighty":-5.820083,"marketCap":217309769},{"date":"2022-09-30","current":-10.452165,"twenty":-12.87166,"median":-8.485618,"eighty":-5.827229,"marketCap":337218196},{"date":"2022-10-07","current":-10.758874,"twenty":-12.827224,"median":-8.662429,"eighty":-5.851527,"marketCap":347113551},{"date":"2022-10-14","current":-10.75286,"twenty":-12.732811,"median":-9.159176,"eighty":-5.887259,"marketCap":346919525},{"date":"2022-10-21","current":-9.868816,"twenty":-12.676035,"median":-9.377444,"eighty":-5.901552,"marketCap":318397617},{"date":"2022-10-28","current":-9.056939,"twenty":-12.658457,"median":-9.321551,"eighty":-5.921562,"marketCap":292204029},{"date":"2022-11-04","current":-9.604204,"twenty":-12.633134,"median":-9.294488,"eighty":-5.955866,"marketCap":309860448},{"date":"2022-11-11","current":-7.870305,"twenty":-12.51788,"median":-9.213301,"eighty":-5.98731,"marketCap":288517524},{"date":"2022-11-18","current":-6.891148,"twenty":-12.343378,"median":-9.131888,"eighty":-6.021613,"marketCap":252622607},{"date":"2022-11-25","current":-5.8326,"twenty":-12.30698,"median":-9.032884,"eighty":-5.94729,"marketCap":213817291},{"date":"2022-12-02","current":-5.102202,"twenty":-12.193952,"median":-8.756244,"eighty":-5.842388,"marketCap":187041623},{"date":"2022-12-09","current":-4.726417,"twenty":-12.185254,"median":-8.550748,"eighty":-5.80579,"marketCap":173265735},{"date":"2022-12-16","current":-5.181593,"twenty":-12.178295,"median":-8.404872,"eighty":-5.725749,"marketCap":189952021},{"date":"2022-12-23","current":-5.043982,"twenty":-12.152199,"median":-8.130215,"eighty":-5.685509,"marketCap":184907330},{"date":"2022-12-30","current":-5.043982,"twenty":-12.047813,"median":-8.043349,"eighty":-5.617123,"marketCap":184907330},{"date":"2023-01-06","current":-5.361546,"twenty":-11.988509,"median":-7.887149,"eighty":-5.544229,"marketCap":196548925},{"date":"2023-01-13","current":-5.642062,"twenty":-11.900765,"median":-7.790914,"eighty":-5.514548,"marketCap":206832334},{"date":"2023-01-20","current":-5.292741,"twenty":-11.857841,"median":-7.780329,"eighty":-5.486455,"marketCap":194026580},{"date":"2023-01-27","current":-6.652975,"twenty":-11.83416,"median":-7.52668,"eighty":-5.481434,"marketCap":243891411},{"date":"2023-02-03","current":-8.256675,"twenty":-11.724707,"median":-7.50379,"eighty":-5.486455,"marketCap":302681464},{"date":"2023-02-10","current":-7.621547,"twenty":-11.591193,"median":-7.550498,"eighty":-5.497097,"marketCap":279398275},{"date":"2023-02-17","current":-7.224591,"twenty":-11.42481,"median":-7.520984,"eighty":-5.503782,"marketCap":264846281},{"date":"2023-02-24","current":-6.409509,"twenty":-11.289301,"median":-7.50379,"eighty":-5.509499,"marketCap":234966188},{"date":"2023-03-03","current":-5.456816,"twenty":-11.208214,"median":-7.426374,"eighty":-5.509499,"marketCap":200041403},{"date":"2023-03-10","current":-4.578221,"twenty":-11.173685,"median":-7.303982,"eighty":-5.480511,"marketCap":167832991},{"date":"2023-03-17","current":-4.684075,"twenty":-11.125722,"median":-7.239128,"eighty":-5.439451,"marketCap":171713523},{"date":"2023-03-24","current":-5.493865,"twenty":-11.125722,"median":-7.16076,"eighty":-5.330785,"marketCap":201399590},{"date":"2023-03-31","current":-4.675853,"twenty":-11.084828,"median":-7.064148,"eighty":-5.270511,"marketCap":191504234},{"date":"2023-04-06","current":-4.230534,"twenty":-11.023486,"median":-6.924927,"eighty":-5.260984,"marketCap":173265735},{"date":"2023-04-14","current":-4.216321,"twenty":-11.019852,"median":-6.821303,"eighty":-5.202027,"marketCap":172683656},{"date":"2023-04-21","current":-4.007874,"twenty":-10.916914,"median":-6.735572,"eighty":-5.163355,"marketCap":164146486},{"date":"2023-04-28","current":-3.789856,"twenty":-10.785335,"median":-6.531871,"eighty":-5.110953,"marketCap":155217351},{"date":"2023-05-04","current":-2.741598,"twenty":-10.756468,"median":-6.516471,"eighty":-5.079973,"marketCap":112284892},{"date":"2023-05-12","current":-2.021591,"twenty":-10.742455,"median":-6.4889,"eighty":-5.044655,"marketCap":98297847},{"date":"2023-05-19","current":-3.128272,"twenty":-10.723989,"median":-6.417091,"eighty":-5.017615,"marketCap":152109119},{"date":"2023-05-26","current":-2.225348,"twenty":-10.658392,"median":-6.345996,"eighty":-4.977293,"marketCap":108205337},{"date":"2023-06-02","current":-2.385158,"twenty":-10.566429,"median":-6.281745,"eighty":-4.901078,"marketCap":115975918},{"date":"2023-06-09","current":-2.560948,"twenty":-10.530346,"median":-6.253159,"eighty":-4.858736,"marketCap":124523557},{"date":"2023-06-16","current":-2.916525,"twenty":-10.482234,"median":-6.179275,"eighty":-4.763467,"marketCap":141813099},{"date":"2023-06-23","current":-2.816644,"twenty":-10.458179,"median":-6.099509,"eighty":-4.692657,"marketCap":136956486},{"date":"2023-06-30","current":-3.356001,"twenty":-10.436883,"median":-6.046964,"eighty":-4.666378,"marketCap":163182196},{"date":"2023-07-07","current":-3.515811,"twenty":-10.412827,"median":-5.988739,"eighty":-4.546389,"marketCap":170952777},{"date":"2023-07-14","current":-3.096311,"twenty":-10.358348,"median":-5.938714,"eighty":-4.379111,"marketCap":150555003},{"date":"2023-07-21","current":-3.096311,"twenty":-10.284978,"median":-5.895835,"eighty":-4.25703,"marketCap":150555003},{"date":"2023-07-28","current":-3.268106,"twenty":-10.193567,"median":-5.832059,"eighty":-4.205213,"marketCap":158908377},{"date":"2023-08-04","current":-3.216168,"twenty":-10.158686,"median":-5.817224,"eighty":-4.029666,"marketCap":156382938},{"date":"2023-08-11","current":-3.356001,"twenty":-10.014353,"median":-5.791146,"eighty":-3.845856,"marketCap":163182196},{"date":"2023-08-18","current":-5.688753,"twenty":-9.981877,"median":-5.731467,"eighty":-3.79935,"marketCap":308944792},{"date":"2023-08-25","current":-8.204932,"twenty":-9.916927,"median":-5.791146,"eighty":-3.845856,"marketCap":445593450},{"date":"2023-09-01","current":-8.226812,"twenty":-9.859194,"median":-5.817224,"eighty":-3.898925,"marketCap":446781699},{"date":"2023-09-08","current":-8.50578,"twenty":-9.820705,"median":-5.831517,"eighty":-3.974712,"marketCap":461931876},{"date":"2023-09-15","current":-7.915024,"twenty":-9.604204,"median":-5.888688,"eighty":-4.007874,"marketCap":429849148},{"date":"2023-09-22","current":-7.554007,"twenty":-9.586163,"median":-5.938714,"eighty":-4.029192,"marketCap":410243036},{"date":"2023-09-29","current":-8.730048,"twenty":-9.561973,"median":-5.988739,"eighty":-4.031561,"marketCap":474111430},{"date":"2023-10-06","current":-8.292451,"twenty":-9.447843,"median":-6.060204,"eighty":-4.121573,"marketCap":450346446},{"date":"2023-10-13","current":-8.068183,"twenty":-9.447843,"median":-6.108187,"eighty":-4.154735,"marketCap":438166892},{"date":"2023-10-20","current":-7.958784,"twenty":-9.433336,"median":-6.21897,"eighty":-4.202436,"marketCap":432225646},{"date":"2023-10-27","current":-8.062713,"twenty":-9.388622,"median":-6.246012,"eighty":-4.20799,"marketCap":437869830},{"date":"2023-11-03","current":-8.204932,"twenty":-9.299901,"median":-6.263879,"eighty":-4.222006,"marketCap":445593450},{"date":"2023-11-10","current":-8.42373,"twenty":-9.245776,"median":-6.345996,"eighty":-4.238114,"marketCap":457475942},{"date":"2023-11-17","current":-8.188416,"twenty":-9.191651,"median":-6.417091,"eighty":-4.251835,"marketCap":488651941},{"date":"2023-11-24","current":-8.592106,"twenty":-9.159176,"median":-6.462436,"eighty":-4.25703,"marketCap":512742511},{"date":"2023-12-01","current":-8.756572,"twenty":-9.148261,"median":-6.515364,"eighty":-4.263696,"marketCap":522557188},{"date":"2023-12-08","current":-9.369582,"twenty":-9.256601,"median":-6.592423,"eighty":-4.286376,"marketCap":559139166},{"date":"2023-12-15","current":-10.181945,"twenty":-9.420585,"median":-6.735572,"eighty":-4.378104,"marketCap":607617721},{"date":"2023-12-22","current":-10.216831,"twenty":-9.539147,"median":-6.886598,"eighty":-4.40653,"marketCap":609699622},{"date":"2023-12-29","current":-10.416184,"twenty":-9.612102,"median":-6.924927,"eighty":-4.479724,"marketCap":621596200},{"date":"2024-01-05","current":-9.638708,"twenty":-9.641698,"median":-7.064148,"eighty":-4.516825,"marketCap":575199546},{"date":"2024-01-12","current":-10.431136,"twenty":-9.849572,"median":-7.123402,"eighty":-4.535879,"marketCap":622488443},{"date":"2024-01-19","current":-9.892883,"twenty":-9.923734,"median":-7.161078,"eighty":-4.541134,"marketCap":590367683},{"date":"2024-01-26","current":-9.912818,"twenty":-9.910825,"median":-7.239128,"eighty":-4.565367,"marketCap":591557341},{"date":"2024-02-02","current":-9.937737,"twenty":-9.925728,"median":-7.28225,"eighty":-4.59301,"marketCap":593044413},{"date":"2024-02-09","current":-9.96764,"twenty":-9.966643,"median":-7.362202,"eighty":-4.656903,"marketCap":594828900},{"date":"2024-02-16","current":-1.918771,"twenty":-9.966643,"median":-7.303982,"eighty":-4.541134,"marketCap":114504563},{"date":"2024-02-23","current":-1.649644,"twenty":-9.962656,"median":-7.2641,"eighty":-4.382132,"marketCap":98444182},{"date":"2024-03-01","current":-1.485178,"twenty":-9.942721,"median":-7.216995,"eighty":-4.255363,"marketCap":88629506},{"date":"2024-03-08","current":-1.465243,"twenty":-9.937737,"median":-7.16076,"eighty":-4.202436,"marketCap":87439848},{"date":"2024-03-15","current":-1.515081,"twenty":-9.928955,"median":-7.0934,"eighty":-4.029192,"marketCap":90413992},{"date":"2024-03-22","current":-1.649644,"twenty":-9.912818,"median":-6.924927,"eighty":-3.837326,"marketCap":98444182},{"date":"2024-03-28","current":-1.60479,"twenty":-9.904844,"median":-6.882048,"eighty":-3.54138,"marketCap":95767452},{"date":"2024-04-05","current":-1.493229,"twenty":-9.894877,"median":-6.735572,"eighty":-3.40709,"marketCap":96659696},{"date":"2024-04-12","current":-1.379706,"twenty":-9.873629,"median":-6.531871,"eighty":-3.34002,"marketCap":89311125},{"date":"2024-04-19","current":-1.094567,"twenty":-9.830327,"median":-6.512717,"eighty":-3.300068,"marketCap":70853492},{"date":"2024-04-26","current":-1.048577,"twenty":-9.7389,"median":-6.435973,"eighty":-3.275297,"marketCap":67876455},{"date":"2024-05-03","current":-1.170453,"twenty":-9.714462,"median":-6.384932,"eighty":-3.243335,"marketCap":75765761},{"date":"2024-05-10","current":-1.138196,"twenty":-9.689543,"median":-6.288891,"eighty":-3.200986,"marketCap":73677728},{"date":"2024-05-17","current":-1.025534,"twenty":-9.683563,"median":-6.253159,"eighty":-3.153842,"marketCap":67711920},{"date":"2024-05-24","current":-0.908072,"twenty":-9.651666,"median":-6.21897,"eighty":-3.096311,"marketCap":59956370},{"date":"2024-05-31","current":-0.899037,"twenty":-9.640702,"median":-6.117376,"eighty":-3.032764,"marketCap":59359789},{"date":"2024-06-07","current":-0.917108,"twenty":-9.626747,"median":-6.070923,"eighty":-2.970061,"marketCap":60552951},{"date":"2024-06-14","current":-0.980356,"twenty":-9.610032,"median":-5.995886,"eighty":-2.875774,"marketCap":64729016},{"date":"2024-06-21","current":-0.95325,"twenty":-9.596988,"median":-5.970211,"eighty":-2.763626,"marketCap":62939274},{"date":"2024-06-28","current":-0.971321,"twenty":-9.576487,"median":-5.902982,"eighty":-2.560948,"marketCap":64132436},{"date":"2024-07-05","current":-1.188174,"twenty":-9.555391,"median":-5.857071,"eighty":-2.458418,"marketCap":78450375},{"date":"2024-07-12","current":-1.165585,"twenty":-9.514113,"median":-5.824371,"eighty":-2.36598,"marketCap":76958923},{"date":"2024-07-19","current":-1.260458,"twenty":-9.453014,"median":-5.802931,"eighty":-2.238133,"marketCap":83223021},{"date":"2024-07-26","current":-1.210763,"twenty":-9.447843,"median":-5.737331,"eighty":-2.128663,"marketCap":79941827},{"date":"2024-08-02","current":-1.165585,"twenty":-9.447142,"median":-5.721772,"eighty":-1.927742,"marketCap":76958923},{"date":"2024-08-09","current":-0.46533,"twenty":-9.442138,"median":-5.694989,"eighty":-1.744863,"marketCap":30723911},{"date":"2024-08-16","current":-0.452319,"twenty":-9.420585,"median":-5.683771,"eighty":-1.649644,"marketCap":29245582},{"date":"2024-08-23","current":-0.507705,"twenty":-9.368585,"median":-5.668525,"eighty":-1.569679,"marketCap":32826674},{"date":"2024-08-30","current":-0.521551,"twenty":-9.363601,"median":-5.629593,"eighty":-1.541673,"marketCap":33721947},{"date":"2024-09-06","current":-0.470781,"twenty":-9.359614,"median":-5.566854,"eighty":-1.505114,"marketCap":30439279},{"date":"2024-09-13","current":-0.480012,"twenty":-9.321551,"median":-5.545658,"eighty":-1.493229,"marketCap":31036128},{"date":"2024-09-20","current":-0.484627,"twenty":-9.274889,"median":-5.510762,"eighty":-1.470227,"marketCap":31334552},{"date":"2024-09-27","current":-0.489243,"twenty":-9.269905,"median":-5.493865,"eighty":-1.445308,"marketCap":31632976},{"date":"2024-10-04","current":-0.493858,"twenty":-9.267426,"median":-5.480973,"eighty":-1.398102,"marketCap":31931401},{"date":"2024-10-11","current":-0.484627,"twenty":-9.213301,"median":-5.440937,"eighty":-1.379706,"marketCap":31334552},{"date":"2024-10-18","current":-0.484627,"twenty":-9.159176,"median":-5.400004,"eighty":-1.260458,"marketCap":31334552},{"date":"2024-10-25","current":-0.493858,"twenty":-9.159176,"median":-5.292741,"eighty":-1.224316,"marketCap":31931401},{"date":"2024-11-01","current":-0.498474,"twenty":-9.104599,"median":-5.27157,"eighty":-1.192692,"marketCap":32229825},{"date":"2024-11-08","current":-0.507705,"twenty":-9.056939,"median":-5.260984,"eighty":-1.175061,"marketCap":32826674},{"date":"2024-11-15","current":-0.492263,"twenty":-9.008828,"median":-5.223935,"eighty":-1.165585,"marketCap":29878890},{"date":"2024-11-22","current":-0.659632,"twenty":-8.984772,"median":-5.186886,"eighty":-1.152032,"marketCap":40037712},{"date":"2024-11-29","current":-0.822079,"twenty":-8.833504,"median":-5.165715,"eighty":-1.14661,"marketCap":49897746},{"date":"2024-12-06","current":-0.708859,"twenty":-8.764395,"median":-5.131312,"eighty":-1.135958,"marketCap":43025601},{"date":"2024-12-13","current":-0.703936,"twenty":-8.75631,"median":-5.107495,"eighty":-1.128429,"marketCap":42726812},{"date":"2024-12-20","current":-0.620251,"twenty":-8.752791,"median":-5.06243,"eighty":-1.10594,"marketCap":37647401},{"date":"2024-12-27","current":-0.708859,"twenty":-8.7388,"median":-5.051921,"eighty":-1.093587,"marketCap":43025601},{"date":"2025-01-03","current":-0.699014,"twenty":-8.706848,"median":-5.044823,"eighty":-1.083887,"marketCap":42428023},{"date":"2025-01-10","current":-0.615329,"twenty":-8.669427,"median":-5.041335,"eighty":-1.044599,"marketCap":37348612},{"date":"2025-01-17","current":-0.625174,"twenty":-8.655656,"median":-5.006933,"eighty":-1.011077,"marketCap":37946190},{"date":"2025-01-24","current":-0.615329,"twenty":-8.642528,"median":-4.99154,"eighty":-0.978098,"marketCap":37348612},{"date":"2025-01-31","current":-0.56118,"twenty":-8.620649,"median":-4.940774,"eighty":-0.957768,"marketCap":34061934},{"date":"2025-02-07","current":-0.531644,"twenty":-8.592106,"median":-4.895785,"eighty":-0.948732,"marketCap":32269201},{"date":"2025-02-14","current":-0.551335,"twenty":-8.592106,"median":-4.864028,"eighty":-0.935179,"marketCap":33464356},{"date":"2025-02-21","current":-0.556257,"twenty":-8.573312,"median":-4.805808,"eighty":-0.928854,"marketCap":33763145},{"date":"2025-02-28","current":-0.56118,"twenty":-8.566482,"median":-4.763467,"eighty":-0.907168,"marketCap":34061934},{"date":"2025-03-07","current":-0.644865,"twenty":-8.539495,"median":-4.726229,"eighty":-0.899037,"marketCap":39141345},{"date":"2025-03-14","current":-0.689168,"twenty":-8.528704,"median":-4.684075,"eighty":-0.782698,"marketCap":41830446},{"date":"2025-03-21","current":-0.718704,"twenty":-8.510156,"median":-4.66401,"eighty":-0.732487,"marketCap":43623179},{"date":"2025-03-28","current":-0.815207,"twenty":-8.48965,"median":-4.562154,"eighty":-0.73741,"marketCap":41837220},{"date":"2025-04-04","current":-0.744829,"twenty":-8.484244,"median":-4.520001,"eighty":-0.742333,"marketCap":38225374},{"date":"2025-04-11","current":-0.750694,"twenty":-8.45484,"median":-4.377097,"eighty":-0.733398,"marketCap":38526361},{"date":"2025-04-17","current":-0.738964,"twenty":-8.433268,"median":-4.263696,"eighty":-0.736426,"marketCap":37924387},{"date":"2025-04-25","current":-0.7331,"twenty":-8.412415,"median":-4.240009,"eighty":-0.733323,"marketCap":37623400},{"date":"2025-05-02","current":-0.715505,"twenty":-8.383057,"median":-4.202436,"eighty":-0.728023,"marketCap":36720438},{"date":"2025-05-09","current":-0.703776,"twenty":-8.368106,"median":-4.076567,"eighty":-0.727235,"marketCap":36118464},{"date":"2025-05-16","current":-0.803022,"twenty":-8.352142,"median":-4.007874,"eighty":-0.727235,"marketCap":36419451},{"date":"2025-05-23","current":-0.789749,"twenty":-8.341681,"median":-3.858652,"eighty":-0.727235,"marketCap":35817476},{"date":"2025-05-30","current":-0.805076,"twenty":-8.337305,"median":-3.749538,"eighty":-0.727235,"marketCap":36512621},{"date":"2025-06-06","current":-0.738541,"twenty":-8.328553,"median":-3.531792,"eighty":-0.727235,"marketCap":33495049},{"date":"2025-06-13","current":-0.751848,"twenty":-8.312143,"median":-3.453864,"eighty":-0.727235,"marketCap":34098563},{"date":"2025-06-20","current":-0.731887,"twenty":-8.285296,"median":-3.37993,"eighty":-0.727235,"marketCap":33193292},{"date":"2025-06-27","current":-0.71858,"twenty":-8.255078,"median":-3.34002,"eighty":-0.72001,"marketCap":32589777},{"date":"2025-07-03","current":-0.69862,"twenty":-8.248692,"median":-3.308058,"eighty":-0.71858,"marketCap":31684506},{"date":"2025-07-11","current":-0.711927,"twenty":-8.237752,"median":-3.300068,"eighty":-0.715505,"marketCap":32288020},{"date":"2025-07-18","current":-0.725234,"twenty":-8.232282,"median":-3.276096,"eighty":-0.715505,"marketCap":32891534},{"date":"2025-07-25","current":-0.731887,"twenty":-8.226812,"median":-3.270104,"eighty":-0.715505,"marketCap":33193292},{"date":"2025-08-01","current":-0.705273,"twenty":-8.204932,"median":-3.244134,"eighty":-0.713781,"marketCap":31986263},{"date":"2025-08-08","current":-0.71858,"twenty":-8.204932,"median":-3.210175,"eighty":-0.711927,"marketCap":32589777},{"date":"2025-08-15","current":-0.771244,"twenty":-8.199462,"median":-3.188201,"eighty":-0.711927,"marketCap":28829104},{"date":"2025-08-22","current":-0.811451,"twenty":-8.188416,"median":-3.162232,"eighty":-0.711927,"marketCap":30332043},{"date":"2025-08-29","current":-0.804141,"twenty":-8.18787,"median":-3.120282,"eighty":-0.713781,"marketCap":30058781},{"date":"2025-09-05","current":-0.921107,"twenty":-8.185512,"median":-3.096311,"eighty":-0.714959,"marketCap":34430967},{"date":"2025-09-12","current":-0.928417,"twenty":-8.183731,"median":-3.036031,"eighty":-0.715455,"marketCap":34704229},{"date":"2025-09-19","current":-0.943038,"twenty":-8.171471,"median":-3.008415,"eighty":-0.715505,"marketCap":35250752},{"date":"2025-09-26","current":-0.906486,"twenty":-8.162634,"median":-2.968463,"eighty":-0.715505,"marketCap":33884444},{"date":"2025-10-03","current":-0.935727,"twenty":-8.156796,"median":-2.88656,"eighty":-0.717965,"marketCap":34977491},{"date":"2025-10-10","current":-0.906486,"twenty":-8.151327,"median":-2.842613,"eighty":-0.71858,"marketCap":33884444},{"date":"2025-10-17","current":-0.862624,"twenty":-8.145857,"median":-2.741598,"eighty":-0.71858,"marketCap":32244874},{"date":"2025-10-24","current":-0.855313,"twenty":-8.140387,"median":-2.608584,"eighty":-0.71858,"marketCap":31971613},{"date":"2025-10-31","current":-0.906486,"twenty":-8.138721,"median":-2.541748,"eighty":-0.71858,"marketCap":33884444},{"date":"2025-11-07","current":-0.818761,"twenty":-8.134774,"median":-2.431944,"eighty":-0.71858,"marketCap":30605304},{"date":"2025-11-14","current":-0.826072,"twenty":-8.105379,"median":-2.385158,"eighty":-0.71858,"marketCap":30878566},{"date":"2025-11-21","current":-0.870776,"twenty":-8.0895,"median":-2.290271,"eighty":-0.71858,"marketCap":29594185},{"date":"2025-11-28","current":-0.878839,"twenty":-8.087308,"median":-2.239332,"eighty":-0.718654,"marketCap":29868206},{"date":"2025-12-05","current":-0.858682,"twenty":-8.080228,"median":-2.177405,"eighty":-0.718704,"marketCap":29183155},{"date":"2025-12-12","current":-0.959466,"twenty":-8.07122,"median":-2.079522,"eighty":-0.718704,"marketCap":32608408},{"date":"2025-12-19","current":-0.919152,"twenty":-8.068254,"median":-1.94369,"eighty":-0.722622,"marketCap":31238307},{"date":"2025-12-26","current":-0.919152,"twenty":-8.065995,"median":-1.918771,"eighty":-0.725234,"marketCap":31238307},{"date":"2026-01-02","current":-0.919152,"twenty":-8.061619,"median":-1.814111,"eighty":-0.725634,"marketCap":31238307},{"date":"2026-01-09","current":-1.064281,"twenty":-8.056565,"median":-1.659612,"eighty":-0.727235,"marketCap":36170671},{"date":"2026-01-16","current":-1.007842,"twenty":-8.046873,"median":-1.649644,"eighty":-0.727235,"marketCap":34252530},{"date":"2026-01-23","current":-0.975591,"twenty":-8.018954,"median":-1.599806,"eighty":-0.727235,"marketCap":33156449},{"date":"2026-01-30","current":-0.911089,"twenty":-8.018954,"median":-1.561041,"eighty":-0.727235,"marketCap":30964287},{"date":"2026-02-06","current":-0.85465,"twenty":-8.018336,"median":-1.548364,"eighty":-0.727235,"marketCap":29046145},{"date":"2026-02-13","current":-0.846588,"twenty":-8.008014,"median":-1.522557,"eighty":-0.728549,"marketCap":28772125},{"date":"2026-02-20","current":-0.878839,"twenty":-7.997233,"median":-1.50013,"eighty":-0.731219,"marketCap":29868206},{"date":"2026-02-27","current":-0.85465,"twenty":-7.965935,"median":-1.493229,"eighty":-0.731887,"marketCap":29046145},{"date":"2026-03-06","current":-1.378728,"twenty":-7.954408,"median":-1.485178,"eighty":-0.731887,"marketCap":46857461},{"date":"2026-03-13","current":-4.38613,"twenty":-7.953314,"median":-1.493229,"eighty":-0.731887,"marketCap":149067010},{"date":"2026-03-20","current":-3.046054,"twenty":-7.948938,"median":-1.50013,"eighty":-0.731887,"marketCap":107141913},{"date":"2026-03-27","current":-3.688739,"twenty":-7.933429,"median":-1.530033,"eighty":-0.731887,"marketCap":129747713},{"date":"2026-04-02","current":-3.525249,"twenty":-7.927508,"median":-1.548364,"eighty":-0.731887,"marketCap":123997122},{"date":"2026-04-10","current":-3.116525,"twenty":-7.925964,"median":-1.561041,"eighty":-0.732615,"marketCap":109620644},{"date":"2026-04-17","current":-3.212452,"twenty":-7.9194,"median":-1.599806,"eighty":-0.7331,"marketCap":112994780},{"date":"2026-04-24","current":-4.379966,"twenty":-7.908405,"median":-1.649644,"eighty":-0.7331,"marketCap":154060932},{"date":"2026-05-01","current":-4.656273,"twenty":-7.894202,"median":-1.659612,"eighty":-0.733323,"marketCap":163779729},{"date":"2026-05-08","current":-4.70744,"twenty":-7.877253,"median":-1.829062,"eighty":-0.736426,"marketCap":165579507},{"date":"2026-05-15","current":-4.833714,"twenty":-7.86479,"median":-1.923755,"eighty":-0.738483,"marketCap":167019328},{"date":"2026-05-22","current":-5.094151,"twenty":-7.847513,"median":-2.027584,"eighty":-0.738541,"marketCap":176018215},{"date":"2026-05-29","current":-4.646199,"twenty":-7.819433,"median":-2.133458,"eighty":-0.738541,"marketCap":160540130},{"date":"2026-06-05","current":-4.344092,"twenty":-7.78668,"median":-2.225348,"eighty":-0.73871,"marketCap":150101422},{"date":"2026-06-12","current":-4.635782,"twenty":-7.780329,"median":-2.261305,"eighty":-0.738964,"marketCap":160180175},{"date":"2026-06-18","current":-5.104569,"twenty":-7.77773,"median":-2.29857,"eighty":-0.739835,"marketCap":176378170},{"date":"2026-06-26","current":-5.357655,"twenty":-7.751023,"median":-2.385158,"eighty":-0.743317,"marketCap":185123067},{"date":"2026-07-02","current":-4.899023,"twenty":-7.685769,"median":-2.421115,"eighty":-0.743317,"marketCap":169275956},{"date":"2026-07-10","current":-4.826059,"twenty":-7.621547,"median":-2.531372,"eighty":-0.744829,"marketCap":166754825},{"date":"2026-07-17","current":-4.867753,"twenty":-7.619647,"median":-2.560948,"eighty":-0.744829,"marketCap":168195471},{"date":"2026-07-24","current":-5.128339,"twenty":-7.614177,"median":-2.722625,"eighty":-0.745194,"marketCap":177199512},{"date":"2026-07-31","current":-5.555701,"twenty":-7.577731,"median":-2.806656,"eighty":-0.749594,"marketCap":191966138},{"date":"2026-08-07","current":-6.33746,"twenty":-7.564385,"median":-2.880568,"eighty":-0.750694,"marketCap":218978258},{"date":"2026-08-14","current":-6.220716,"twenty":-7.555871,"median":-2.938499,"eighty":-0.751617,"marketCap":225662697},{"date":"2026-08-21","current":-6.023068,"twenty":-7.536702,"median":-2.976453,"eighty":-0.751848,"marketCap":218492812},{"date":"2026-08-28","current":-5.971055,"twenty":-7.523426,"median":-3.031586,"eighty":-0.751848,"marketCap":216606000},{"date":"2026-08-31","current":-5.804615,"twenty":-7.521188,"median":-3.03478,"eighty":-0.751848,"marketCap":210568202}],"updateTime":1788335161578},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664885739","title":"AN2 Therapeutics presents clinical data supporting development of Epetraborole","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885739","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885739?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:05","pubTimestamp":1788213906,"startTime":"0","endTime":"0","summary":"The company states: “AN2 Therapeutics (ANTX) announced that four abstracts highlighting clinical and nonclinical data supporting the development of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/an2-therapeutics-presents-clinical-data-supporting-development-of-epetraborole-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/an2-therapeutics-presents-clinical-data-supporting-development-of-epetraborole-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANTX","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885998","title":"AN2 Therapeutics Presents SOHO 2026 Data Backing Epetraborole Development for Polycythemia Vera","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885998?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:00","pubTimestamp":1788213622,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics presents SOHO 2026 data backing epetraborole development for polycythemia veraAN2 Therapeutics flagged new clinical and translational data supporting epetraborole as an oral candidate for polycythemia vera.Results will be presented at the SOHO 2026 Annual Meeting on Sept. 9-12 in Houston.Studies showed potential beneficial effects on red blood cell production and hemoglobin-related measures across healthy volunteers, non-PV patients, and primates.Nonhuman primate exposure-response patterns aligned with effects later seen in humans, supporting translational relevance for ongoing development in PV.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL52QRv8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662597087","title":"AN2 Therapeutics Names Cameron Trenor III as Chief Medical Officer in Initial Beneficial Ownership Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662597087","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662597087?lang=en_us&edition=fundamental","pubTime":"2026-08-28 02:16","pubTimestamp":1787854605,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics names Cameron Trenor III as chief medical officer in initial beneficial ownership filingAN2 Therapeutics filed a Form 3 naming Cameron C. Trenor III as chief medical officer, dated Au","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL6YqXnc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273328","title":"AN2 Therapeutics Names Cameron Trenor Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273328","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273328?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569227,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics names Cameron Trenor chief medical officerAN2 Therapeutics appointed Cameron Trenor as chief medical officer.Trenor most recently served as chief medical officer at Cellarity, buildin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL2SG4qD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661527333","title":"AN2 Therapeutics Appoints Cameron Trenor, M.d., as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661527333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661527333?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA6PSJY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660147636","title":"AN2 Therapeutics Director Robin Shane Readnour Disposes of USD 212,486 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660147636","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660147636?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:59","pubTimestamp":1787176755,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics director Robin Shane Readnour disposes of USD 212,486 common sharesAN2 Therapeutics director Robin Shane Readnour reported sales of 35,402 common shares on Aug. 17.Shares sold at a we","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL300C5K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AN2 Therapeutics Director Robin Shane Readnour Disposes of USD 212,486 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943586","title":"AN2 Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943586","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943586?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:15","pubTimestamp":1786479339,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryAN2 Therapeutics IncANTX.OQreported a quarterly adjusted loss of 18 cents per share for the quarter ended June 30, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44821Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658694838","title":"AN2 Therapeutics Rugi Bersih Q2 FY26 Melebar Jadi $ 8,19 Juta; Belanja R&D Naik 88,09% Jadi $ 6,02 Juta","url":"https://stock-news.laohu8.com/highlight/detail?id=2658694838","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658694838?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:00","pubTimestamp":1786478436,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics rugi bersih Q2 FY26 melebar jadi $ 8,19 juta; belanja R&D naik 88,09% jadi $ 6,02 jutaAN2 Therapeutics membukukan rugi bersih USD 8,19 juta pada kuartal II 2026, melebar dari USD 6,46","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL9f62Wm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948874","title":"AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948874?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:00","pubTimestamp":1786478400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA4VKDQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658840948","title":"AN2 Therapeutics Q2 Net Income USD -8.185 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658840948","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658840948?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:00","pubTimestamp":1786478400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX2W76PJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642560","title":"AN2 Therapeutics Inc Expected to Post a Loss of 27 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642560","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642560?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:50","pubTimestamp":1786114205,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc <ANTX.OQ> expected to post a loss of27cents a share - Earnings PreviewAN2 Therapeutics IncANTX.OQANTX.Ois expected to  show no change in quarterly revenue when it reports  results on August 10  for the period ending June 30 2026LSEG's mean analyst estimate for AN2 Therapeutics Inc is for a loss of 27 cents per share.The current average analyst rating on the shares is \"strong buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy,\" no \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for AN2 Therapeutics Inc is $9.00, about 48% above its last closing price of $6.08This summary was machine generated August 7 at 14:50 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652139952","title":"AN2 Therapeutics Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2652139952","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652139952?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:14","pubTimestamp":1784549640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANTX/analyst-ratings(END) Dow Jones NewswiresJuly 20, 2026 08:14 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","ANTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652293628","title":"U.S. Research Roundup- Anterix, Fidus Investment, Nextpower","url":"https://stock-news.laohu8.com/highlight/detail?id=2652293628","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652293628?lang=en_us&edition=fundamental","pubTime":"2026-07-20 15:39","pubTimestamp":1784533199,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Anterix, Fidus Investment, NextpowerJuly 20 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Anterix","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nL4N43M0FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFC","ED","TRV","FITB","VOX","MNST","RRX","BETZ","KMT","EXI","NXT","POOL","MWH","IAK","FE","ENPH","ELOX","BBIO","ATAI","ROK","KBWP","RSI","PLNT","ATEX","AIG","ICLN","VCLN","KKR","ZAP","ANTX","TKR","TMUS","ES","FRVO","AEP","BX","GE","KNSL","IAT","T","CHTR","DFEN","IPGP","VZ","FDUS","NPO","PLMR","ITA","CMCSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652795263","title":"AN2 Therapeutics initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2652795263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652795263?lang=en_us&edition=fundamental","pubTime":"2026-07-20 08:50","pubTimestamp":1784508604,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of AN2 Therapeutics (ANTX) with a Buy rating and $9 price target Published first on TheFly – the ultimate source for ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/an2-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/an2-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","ANTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652283964","title":"One new option listing on July 17th","url":"https://stock-news.laohu8.com/highlight/detail?id=2652283964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652283964?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:35","pubTimestamp":1784291759,"startTime":"0","endTime":"0","summary":"New option listings for July 17th include AN2 Therapeutics Inc (ANTX). Published first on TheFly – the ultimate source for real-time, market-moving...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/one-new-option-listing-on-july-17th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/one-new-option-listing-on-july-17th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642469544","title":"AN2 Therapeutics shareholders elect Class I directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642469544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642469544?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:01","pubTimestamp":1780999303,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics held its annual shareholder meeting on June 3, 2026.Stockholders backed the selection of three Class I director nominees to serve through the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL12KXjt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640715275","title":"AN2 Therapeutics Says Chagas Disease Drug Shows Positive Preclinical, Early Human Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2640715275","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640715275?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:04","pubTimestamp":1780574643,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics  said Thursday its experimental drug, AN2-502998, to treat chronic Chagas disease caused by infection with the parasite T. cruzi showed efficacy in a nonhuman primate study and was generally well tolerated in a Phase 1 study in healthy volunteers.The drug developer said a 28-day treatment led to 100% elimination of the parasite, with effects lasting four months after treatment ended in non-human primates with naturally acquired infection.The company said the exposure levels required in animals are achievable in humans.In a phase 1 study in healthy volunteers, multiple ascending doses were generally well tolerated and showed drug levels consistent with those linked to efficacy in animal studies, it added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4539","BK4139","BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640510991","title":"AN2 Therapeutics says oral AN2-502998 clears T. cruzi in primate study, supports Phase 2 in chronic Chagas disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2640510991","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640510991?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:01","pubTimestamp":1780570870,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics reported positive enabling data for oral AN2-502998, supporting advancement into a Phase 2 study for chronic Chagas disease.Results have already been presented from a nonhuman primate study showing parasite elimination that persisted for months post-treatment.A completed Phase 1 first-in-human study indicated the drug was generally well tolerated, supporting continued development.The company plans to start a Phase 2 proof-of-concept trial late this year, targeting adults with chronic infection.The program aims to address a market with no FDA-approved adult treatment, positioning AN2-502998 as a potential first-in-class option.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL6qhglp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640151796","title":"AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2640151796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640151796?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA669TDV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640115172","title":"AN2 Therapeutics - Phase 1 Study Shows Favorable Safety and No Dose-Limiting Toxicities for AN2-502998","url":"https://stock-news.laohu8.com/highlight/detail?id=2640115172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640115172?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA669TDV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}]}}